OKUR OnKure Therapeutics reports narrower Q4 2025 loss than estimates shares drop 204 percent in trading US Labor Market Job Interview Competency Trends and Candidate Success Best Practices ATHE Alterity publishes latest quarterly earnings report outlining new advancement plans for its lead neurological drug candidate Is Middleby MIDD stock a good option for investors Middleby posts 43 EPS beat topping consensus analyst forecasts SHF SHFSW Stock Is It Breaking Key Structure Froths 20260427